July 15th, 2025
The first collaboration day between the Hospital del Mar Research Institute and the Institute for Bioengineering of Catalonia (IBEC) was held today at the Barcelona Biomedical Research Park (PRBB). The meeting provided an opportunity to share research projects, identify areas for collaboration and formalise a strategic alliance through the signing of a collaboration agreement between the Hospital del Mar and the Hospital del Mar Research Institute and IBEC.
Read more sobre "Hospital del Mar and IBEC formalise a new collaboration"
July 16, 2025
These molecules act as small building blocks that regulate the cellular response by switching certain internal signals on or off. This is the conclusion of an international study led by the Hospital del Mar Research Institute, published in the journal Nature Communications. The findings may help develop more precise drugs to treat various diseases more effectively, while avoiding side effects.
Read more sobre "Amino acids play a key role in how cells respond to drugs"
July 10th, 2025
The journal Cancer Cell has published a study led by the Hospital del Mar Research Institute, together with researchers from GEICAM, identifying malignant cells carrying the TIM-3 protein as a central factor in their ability to generate breast cancer metastasis. This molecule allows cancer cells to survive the most critical and challenging stage of metastasis-when they first reach a new organ-by evading immune system attacks. At the same time, it may serve as a marker of poor prognosis and metastasis risk in patients with TIM-3-positive tumors. This discovery opens the door to the potential use of treatments that block TIM-3 to prevent metastasis before it becomes clinically evident.
29 de setembre al 30 d'octubre de 2025
1 al 3 de octubre de 2025
Parc Salut Mar
Passeig Marítim 25-29 Barcelona 08003
See location on Google maps
Phone: 93 248 30 00 · Fax: 93 248 32 54
Information request
© 2006 - 2025 Hospital del Mar · Legal notice and Privacy Police | Cookie Policy | Accessibility